Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

COVID-19: BCG As Therapeutic Vaccine, Transmission Limitation, and Immunoglobulin Enhancement (BATTLE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04369794
Recruitment Status : Recruiting
First Posted : April 30, 2020
Last Update Posted : August 7, 2020
Sponsor:
Collaborators:
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Instituto de Infectologia Emílio Ribas
Pontifícia Universidade Católica de Campinas, PUC-Campinas
Faculty of Medicine of Ribeirão Preto (FMRP-USP)
Faculdade de Medicina de Botucatu, UNESP, Botucatu, Brasil
Federal University of São Paulo
State Hospital Dr. Leandro Franceschini, Sumaré, Unicamp
Paulinia Municipal Hospital
Information provided by (Responsible Party):
Leonardo Oliveira Reis, University of Campinas, Brazil

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : June 2021
Estimated Study Completion Date : August 2023